Co-Diagnostics, Inc.

NasdaqCM:CODX Stock Report

Market Cap: US$18.0m

Co-Diagnostics Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Dwight Egan

Chief executive officer

US$716.9k

Total compensation

CEO salary percentage54.63%
CEO tenure12.5yrs
CEO ownership1.3%
Management average tenure1.5yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

User avatar

Co-Dx PCR Platform And FDA 510(K) Clearance Will Expand Market Reach

Advancements in PCR platform and manufacturing enhance commercialization, potentially increasing revenues and profit margins through scale efficiencies.

Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans?

Feb 25
Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation

Jun 14
Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation

One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%

May 18
One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%

A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Apr 14
A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics: Hold Thesis Remains Well Intact

Sep 07

Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes

Aug 11

Co-Diagnostics spikes on shipments of monkeypox test

Jul 11

Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Jul 06
Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics: Well Priced, Long-Term Value Remains Too Distant

Jun 21

Co-Diagnostics: Where's Eikon?

Apr 03

Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Mar 28
Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Co-Diagnostics: Swinging For The Fences

Jan 24

Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Dec 28
Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

CEO Compensation Analysis

How has Dwight Egan's remuneration changed compared to Co-Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-US$36m

Mar 31 2025n/an/a

-US$36m

Dec 31 2024US$717kUS$392k

-US$38m

Sep 30 2024n/an/a

-US$41m

Jun 30 2024n/an/a

-US$38m

Mar 31 2024n/an/a

-US$39m

Dec 31 2023US$1mUS$375k

-US$35m

Sep 30 2023n/an/a

-US$43m

Jun 30 2023n/an/a

-US$38m

Mar 31 2023n/an/a

-US$32m

Dec 31 2022US$2mUS$366k

-US$14m

Sep 30 2022n/an/a

US$15m

Jun 30 2022n/an/a

US$28m

Mar 31 2022n/an/a

US$40m

Dec 31 2021US$2mUS$350k

US$37m

Sep 30 2021n/an/a

US$42m

Jun 30 2021n/an/a

US$46m

Mar 31 2021n/an/a

US$51m

Dec 31 2020US$1mUS$309k

US$42m

Sep 30 2020n/an/a

US$28m

Jun 30 2020n/an/a

US$10m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$460kUS$275k

-US$6m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$474kUS$275k

-US$6m

Compensation vs Market: Dwight's total compensation ($USD716.92K) is about average for companies of similar size in the US market ($USD609.46K).

Compensation vs Earnings: Dwight's compensation has been consistent with company performance over the past year.

CEO

Dwight Egan (72 yo)

12.5yrs
Tenure
US$716,917
Compensation

Mr. Dwight H. Egan serves as the Chairman & Chief Executive Officer and was President at Co-Diagnostics, Inc. and has been its Director since April 2013. Mr. Egan has been engaged in private investment bus...

Leadership Team

NamePositionTenureCompensationOwnership
Dwight Egan
Chairman & CEOno dataUS$716.92k1.32%
$ 237.8k
Richard Abbott
President1.6yrsUS$480.20k1.31%
$ 236.7k
Brian Brown
CFO & Company Secretary4.7yrsUS$578.08k1.05%
$ 189.6k
David Nielsen
Chief Operating Officer1.5yrsno datano data
Dan Bohrer
Vice President of Finance & Accountingno datano datano data
Christopher Thurston
Chief Technology Officer1.5yrsno datano data
Andrew Benson
Head of Investor Relationsno datano datano data
Mayuranki Almaula
Senior Vice President of Overseas Operations & Strategic Alliancesno datano datano data
Seth Egan
Chief Commercialization Officer1.5yrsno datano data
1.5yrs
Average Tenure
53yo
Average Age

Experienced Management: CODX's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Dwight Egan
Chairman & CEO12.5yrsUS$716.92k1.32%
$ 237.8k
Richard Serbin
Independent Director8.4yrsUS$222.10k0.44%
$ 80.3k
Carl Wittwer
Chairman of Scientific Advisory Board3.6yrsno datano data
James Nelson
Independent Director6.2yrsUS$222.10k0.44%
$ 79.3k
Noriko Kusukawa
Member of Scientific Advisory Board3.6yrsno datano data
Edward Murphy
Independent Director6.3yrsUS$222.10k0.47%
$ 84.0k
Eugene Durenard
Independent Director6.3yrsUS$222.10k0.44%
$ 79.3k
Karen Carroll
Member of Scientific Advisory Board3.6yrsno datano data
6.3yrs
Average Tenure
66yo
Average Age

Experienced Board: CODX's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/08 05:37
End of Day Share Price 2025/10/08 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Co-Diagnostics, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason KolbertD. Boral Capital LLC.
Yi ChenH.C. Wainwright & Co.
James SidotiSidoti & Company, LLC